6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
8m ago	ProWood TrueFrame Joist Now Available Across Northeast, South Atlantic
9m ago	Parker to Acquire CIRCOR’s Commercial and Defense Aerospace Business
9m ago	Toll Brothers Announces Cedar Terrace Community Now Open in Chantilly, Virginia
9m ago	When Blood Compatibility Becomes a Pregnancy Risk
9m ago	Tony and Grammy Award-Winning Leslie Odom, Jr. to Headline Blackbaud's bbcon 2026 Social Impact Tech Conference

About

231.85USD+1.23 +0.53%

Closed • Updated at 13:56 GMT+00:00

Market Cap$11.93B

Volume26.6K

Beta0.41

RSI71.20

Gross Margin91.30%

Health TechnologyBiotechnology

Axsome Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Axsome Therapeutics Recognizes Mental Health Month

Axsome Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

Axsome Therapeutics Hosts AUVELITY® FDA Approval Investor Event Featuring Expert Thought Leader

Axsome Therapeutics Announces FDA Approval of AUVELITY® (dextromethorphan HBr and bupropion HCl) for the Treatment of Agitation Associated with Dementia due to Alzheimer’s Disease

Axsome Therapeutics to Report First Quarter 2026 Financial Results on May 4

Community Chat

Ask AI